Purchases and Sales Made in Q1 2024 in Fennec Pharmaceuticals Inc. (FENC)
This table provides information about the institutional ownership of Fennec Pharmaceuticals Inc. (FENC) during Q1 2024. The information is specifically focused on institutions that hold shares of FENNEC PHARMACEUTICALS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.05K- 3.95% |
$26.9K - $33.9K
|
74.1K
$623K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.05K- 3.95% |
$26.9K - $33.9K
|
74.1K
$623K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.28K- 25.01% |
$28.9K - $36.4K
|
9.82K
$82.6K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-6.51K- 91.61% |
$57.4K - $72.3K
|
596
$5.01K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-7.13K- 0.76% |
$62.8K - $79.2K
|
927K
$7.8M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-12.2K- 48.65% |
$108K - $136K
|
12.9K
$108K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-23.6K- 58.86% |
$208K - $262K
|
16.5K
$139K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-28K- 27.42% |
$247K - $311K
|
74.1K
$623K
|
|
|
May 15, 2024
Q1 2024
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-91.9K- 65.64% |
$810K - $1.02M
|
48.1K
$405K
|
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-126K- 11.09% |
$1.12M - $1.41M
|
1.01M
$8.52M
|
|
|
May 13, 2024
Q1 2024
|
Worth Venture Partners, LLC
Fort Lee, NJ |
SELL
|
- |
-131K- 92.7% |
$1.16M - $1.46M
|
10.3K
$86.9K
|
|
|
May 15, 2024
Q1 2024
|
Solas Capital Management, LLC
Darien, CT |
SELL
|
- |
-268K- 19.46% |
$2.37M - $2.98M
|
1.11M
$9.34M
|